Tandem Diabetes Care, Inc. - Common Stock — Statistiche Finanziarie Trimestrali (NASDAQ:TNDM)

Financials

Flusso di cassa derivante dalle attività operative 10.72 M-18.28 M-9.5 M8.26 M9.79 M11.05 M 19.61 M Flussi di cassa derivanti dalle attività di investimento 5.01 M9.19 M58.13 M20.54 M-14.98 M-195.45 M -131.76 M Liquidità derivante dalle attività di finanziamento 2.3 M-4.69 M-39.71 M-1.57 M2.6 M274.16 M 235.48 M Liquidità libera 10.72 M-18.28 M-9.5 M8.26 M9.79 M11.05 M 19.61 M

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.

TNDM

Financials

Tandem Diabetes Care, Inc. - Common Stock

Notizie

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Tandem Diabetes Care terminerà il rapporto con il Chief Commercial Officer

TNDM Stock Down Following Q1 Earnings & Revenue Beat, Gross Margin Up

Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?

Tandem Diabetes Care, Inc. (TNDM) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Tandem Diabetes Care (TNDM) Loses 26.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Benchmark avvia copertura su Tandem Diabetes con Hold per cambio canale

Relazione sugli utili: Tandem Diabetes Care Q1 2026 registra vendite record, il titolo cala

Tandem Diabetes Care, Inc. (TNDM) Q1 2026 Earnings Call Transcript

Company News for May 8, 2026

Tandem Diabetes Q1 2026: ricavi record, ritorno alla redditività

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates